With the United Kingdom’s recent rollout of the Pfizer/BionTech Covid-19 vaccine, and Canada expecting to follow suit before the end of December, the U.S. Food and Drug Administration will meet today on whether the vaccine should be approved for use in the U.S.

The meeting consists of a panel of outside experts that advises the government. The experts will discuss the efficacy of the vaccine in terms of safety and effectiveness. One of the issues that is likely to be discussed is adverse allergic events and how to address them, after two nurses in the UK had severe allergic reactions to the vaccine.

There also will be a public hearing, followed by a committee discussion and vote.  The meeting is expected to take the entire day.

If the FDA clears the drug for use, the rollout for administration  could come as early next week.